Xuetao Lei

495 total citations
10 papers, 342 citations indexed

About

Xuetao Lei is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuetao Lei has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuetao Lei's work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xuetao Lei is often cited by papers focused on RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Xuetao Lei collaborates with scholars based in China, South Korea and United States. Xuetao Lei's co-authors include Guoxin Li, Yanmei Peng, Liying Zhao, Ru Li, Junhao Huang, Qiang Ma, Ziqing Wang, Ruoyu Ling, Qingbin Yang and Gengtai Ye and has published in prestigious journals such as Advanced Science, Cell Death and Disease and Theranostics.

In The Last Decade

Xuetao Lei

10 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuetao Lei China 7 238 163 156 48 35 10 342
Xu Shi China 12 146 0.6× 153 0.9× 165 1.1× 58 1.2× 28 0.8× 24 316
Di Gu China 11 201 0.8× 117 0.7× 189 1.2× 83 1.7× 29 0.8× 37 399
Xiufeng Xie China 8 247 1.0× 216 1.3× 104 0.7× 41 0.9× 19 0.5× 10 333
Junqing Hou China 11 292 1.2× 280 1.7× 85 0.5× 58 1.2× 35 1.0× 25 428
Wensu Wei China 12 241 1.0× 103 0.6× 75 0.5× 44 0.9× 48 1.4× 33 312
Yongqiang Huang China 8 256 1.1× 218 1.3× 188 1.2× 88 1.8× 49 1.4× 19 407
Xianyu Hu China 9 225 0.9× 175 1.1× 102 0.7× 85 1.8× 34 1.0× 18 345
Jingsheng Yuan China 11 256 1.1× 203 1.2× 100 0.6× 57 1.2× 21 0.6× 26 365
Jinsen Zheng China 8 258 1.1× 258 1.6× 147 0.9× 80 1.7× 19 0.5× 10 395
Fangshi Xu China 13 232 1.0× 210 1.3× 206 1.3× 123 2.6× 25 0.7× 27 396

Countries citing papers authored by Xuetao Lei

Since Specialization
Citations

This map shows the geographic impact of Xuetao Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuetao Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuetao Lei more than expected).

Fields of papers citing papers by Xuetao Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuetao Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuetao Lei. The network helps show where Xuetao Lei may publish in the future.

Co-authorship network of co-authors of Xuetao Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Xuetao Lei. A scholar is included among the top collaborators of Xuetao Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuetao Lei. Xuetao Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yu, Yan, Qichen Chen, Jiayong He, et al.. (2025). UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancer. Communications Biology. 8(1). 1208–1208. 1 indexed citations
2.
Lei, Xuetao, Yanmei Peng, Guofan Zhang, et al.. (2025). Targeting the NAT10/XIST/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer. International Journal of Biological Sciences. 21(11). 4997–5014. 1 indexed citations
3.
He, Jingdong, et al.. (2025). Identification the Cellular Senescence Associated lncRNA LINC01579 in Gastric Cancer. Journal of Cellular and Molecular Medicine. 29(2). e70360–e70360. 1 indexed citations
4.
Peng, Yanmei, Xuetao Lei, Qingbin Yang, et al.. (2024). Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer. Experimental & Molecular Medicine. 56(2). 441–452. 18 indexed citations
5.
Peng, Yanmei, Wenbo Zheng, Yuehong Chen, et al.. (2024). POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase. Cell Death and Disease. 15(4). 248–248. 7 indexed citations
6.
Yang, Qingbin, Xuetao Lei, Jiayong He, et al.. (2023). N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop. Advanced Science. 10(23). e2300898–e2300898. 55 indexed citations
7.
Yang, Qingbin, Xuetao Lei, Jiayong He, et al.. (2023). N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop (Adv. Sci. 23/2023). Advanced Science. 10(23). 7 indexed citations
8.
Wang, Hao, Jing Wu, Ruoyu Ling, et al.. (2022). Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer. Molecular Therapy — Oncolytics. 24. 547–560. 11 indexed citations
9.
Zhao, Liying, Yanmei Peng, Ru Li, et al.. (2021). Apatinib induced ferroptosis by lipid peroxidation in gastric cancer. Gastric Cancer. 24(3). 642–654. 113 indexed citations
10.
Ye, Gengtai, Qingbin Yang, Xuetao Lei, et al.. (2020). Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis. Theranostics. 10(17). 7545–7560. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026